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The differences in E etween patients who 
experienced acute re on and those who did 
were significant (ple0.001). The EF decrease in patients 
with late patency did not differ from that in patients 
with persistent occlusion. Treatment with streptokinase 
did not fnfluence EF ebang assoclatad with late patency. 
Conclusion: oes not preserve EF regardless 
wheth Lt occurs after thrombolytic therapy or 
spontaneously. 
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: Late thr ic t&es for acute MI results 
in improved Thallium uptake, independent of MI location. 
This finding suggests that the observed mortality 
reduction results at least in part from salvage of 
qocardium. 
